Alpha memo: metformin resistance cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. The author must explicitly state the findings of both Receipt 1 and Receipt 2.
2. The author must explain exactly how the second receipt 'reverses' or 'splits' the signal of the first (e.g., 'While rat data showed additive effects, human data showed attenuation').
3. The memo needs to move from describing the 'geometry' of the search to reporting the actual evidence.

Major issues

• The memo fails to actually state the 'signal' or the result of the comparison. It describes the *question* (Does metformin modify the effect...?) but does not report the *finding* from the cited receipts.
• The 'One-sentence alpha' is a description of a research gap/question, not a research signal or a conclusion based on evidence.
• The synthesis is non-existent; it is a list of two receipts with an abstract that describes the intent to update a belief, but provides no actual data or conclusion from the papers to support that update.

Reviewer note

The submission is structurally broken as an evidence map. It identifies two papers but fails to synthesize their results into a claim. The 'alpha' provided is a meta-commentary on the process of updating beliefs rather than a report of a specific research signal. It asks a question ('Does metformin modify...?') but does not provide the answer derived from the cited evidence. Because the central claim is missing and the synthesis is empty, this requires a total scope reset and rewrite.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis